ABSTRACT. The prophylactic efficacy of desmopressin acetate (DDAVP) on diabetes insipidus (DI) after hypophysectomy was investigated in the dog. In the control group, hypernatremia with a plasma level of 155 mEq/l or higher persisted for 12 hr from the 4th to the 16th hour after hypophysectomy, and symptoms of DI developed within five days after surgery. In the DDAVP treatment group, these changes were not observed, showing that administration of DDAVP (4 µg, instillation, twice daily) effectively prevented hypernatremia that develops immediately after surgery and DI-like symptoms that persists for about one week after surgery. KEY WORDS: canine, desmopressin acetate, hypophysectomy.J. Vet. Med. Sci. 65(1): 17-22, 2003 As modern imaging procedures such as magnetic resonance imaging and computed tomography have become widely used in the field of veterinary medicine, the precision of antemortem diagnosis of pituitary tumor has increased in recent years [3,7]. In veterinary neurosurgery, transsphenoidal hypophysectomy is recognized as useful for pituitary adenoma of the anterior and intermediate lobes accompanied by Cushing's syndrome in dogs and cats, and these surgical procedures and results of such surgery in clinical cases have been reported [6,7,9,12]. However, total resection of pituitary tissue, which plays a central role in endocrine function, induces endocrinological abnormalities after surgery such as diabetes insipidus (DI), hypoadrenocorticism, and hypothyroidism, requiring careful postoperative management mainly by hormone supplementation therapy. Among these pituitary hormone deficiencies, DI due to antidiuretic hormone (ADH) deficiency is an important clinical problem encountered soon after surgery because it causes the loss of a large volume of hypotonic fluid into urine, hypernatremia, and an acute decrease in the circulating blood volume, which may induce hypovolemic shock [18]. In the field of veterinary medicine, a V2-receptor selective agonist, desmopressin acetate (generic name: 1-deamino-8-D-argininevasopressin acetate trihydrate, DDAVP), is used to treat spontaneous central DI [1,21]. The use of DDAVP for management of postoperative DI after hypophysectomy in the dog with pituitary tumor was reported [7]. In that report, however, the dogs had endocrinological abnormalities before surgery caused by pituitary tumor, and surgery was followed by hormone supplement therapy using glucocorticoids, mineralcorticoids, and thyroid hormones. Therefore, it was difficult to evaluate the efficacy of DDAVP alone for postoperative DI after hypophysectomy. In this study, we evaluated fluid and electrolyte abnormalites due to antidiuretic hormone deficiency after surgery and investigated the prophylactic efficacy of DDAVP on DI in the dog after hypophysectomy.
MATERIALS AND METHODSExperimental animals: Clinically healthy beagles, seven males and three females (mean age 3.6 years, mean body weight 12.5 kg), were used. No abnormality was observed in physical examination, complete blood count, biochemistry, a...